Golden State Wealth Management LLC acquired a new stake in Synopsys, Inc. (NASDAQ:SNPS – Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm acquired 145 shares of the semiconductor company’s stock, valued at approximately $70,000.
Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Brookstone Capital Management grew its stake in Synopsys by 25.5% during the 3rd quarter. Brookstone Capital Management now owns 935 shares of the semiconductor company’s stock valued at $473,000 after acquiring an additional 190 shares in the last quarter. Gateway Investment Advisers LLC grew its position in shares of Synopsys by 9.8% in the third quarter. Gateway Investment Advisers LLC now owns 772 shares of the semiconductor company’s stock valued at $391,000 after purchasing an additional 69 shares in the last quarter. Exchange Traded Concepts LLC increased its holdings in shares of Synopsys by 170.0% in the third quarter. Exchange Traded Concepts LLC now owns 7,739 shares of the semiconductor company’s stock valued at $3,919,000 after purchasing an additional 4,873 shares during the last quarter. Compagnie Lombard Odier SCmA lifted its position in Synopsys by 35.8% during the third quarter. Compagnie Lombard Odier SCmA now owns 1,830 shares of the semiconductor company’s stock worth $927,000 after buying an additional 482 shares in the last quarter. Finally, Redhawk Wealth Advisors Inc. boosted its stake in Synopsys by 3.2% during the third quarter. Redhawk Wealth Advisors Inc. now owns 5,797 shares of the semiconductor company’s stock worth $2,936,000 after buying an additional 182 shares during the last quarter. Institutional investors and hedge funds own 85.47% of the company’s stock.
Insider Buying and Selling
In other Synopsys news, CRO Richard S. Mahoney sold 20,838 shares of the business’s stock in a transaction dated Wednesday, January 15th. The shares were sold at an average price of $506.01, for a total transaction of $10,544,236.38. Following the sale, the executive now directly owns 1,460 shares in the company, valued at $738,774.60. This represents a 93.45 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. 0.66% of the stock is owned by corporate insiders.
Analyst Ratings Changes
Get Our Latest Analysis on Synopsys
Synopsys Stock Up 1.0 %
NASDAQ:SNPS opened at $531.33 on Tuesday. Synopsys, Inc. has a 52 week low of $457.52 and a 52 week high of $629.38. The stock’s fifty day moving average is $513.49 and its two-hundred day moving average is $518.39. The stock has a market capitalization of $82.13 billion, a price-to-earnings ratio of 36.59, a price-to-earnings-growth ratio of 3.49 and a beta of 1.12.
Synopsys Profile
Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.
Read More
- Five stocks we like better than Synopsys
- Health Care Stocks Explained: Why You Might Want to Invest
- Merck: 4 No-Brainer Reasons to Buy This Dip
- NYSE Stocks Give Investors a Variety of Quality Options
- Ackman Announces Major Stake in Uber: Should You Follow His Lead?
- How to Use High Beta Stocks to Maximize Your Investing Profits
- Wells Fargo Upgraded These 3 Stocks—Here’s Why They Stand Out
Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS – Free Report).
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.